Stockreport

DATROWAY® (datopotamab deruxtecan-dlnk) granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immuno...

AstraZeneca PLC Ordinary Shares  (AZN) 
Last astrazeneca plc ordinary shares earnings: 2/5 04:00 pm Check Earnings Report
US:NYSE Investor Relations: astrazeneca.com/investor-relations.html
PDF If approved, DATROWAY could become the standard of care in this setting WILMINGTON, Del., February 03, 2026 BUSINESS WIRE )--AstraZeneca and Daiichi Sankyo's suppleme [Read more]